Fusion Antibodies

Fusion Antibodies is an antibody development partner offering research and development services for organisations advancing antibody-based projects. Based in Belfast, the company works with clients as an extension of their teams, supporting project requirements while considering longer-term manufacturability and commercialisation goals. Its stated end-to-end service spans antigen design through cell line development, helping clients address the challenges of progressing antibodies toward clinical use.

The company’s services cover antibody discovery and engineering, including antibody humanisation, reformatting, developability assessment and affinity maturation. It also provides transient protein expression, antibody characterisation and cell line development, as well as antibody supply. Together, these capabilities allow clients to access support across multiple stages of antibody development through one partner.

Fusion Antibodies shares client testimonials, case studies, expert insights, news and event updates through its website. The company also provides investor information and maintains sections covering its leadership, board and scientific advisory panel. Its Belfast office serves as the listed contact location for prospective partners seeking to discuss a project or learn more about its services.